Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Daito Pharmaceutical Revenue

In the fiscal year ending May 31, 2026, Daito Pharmaceutical had annual revenue of 50.65B JPY with 0.01% growth. Daito Pharmaceutical had revenue of 13.92B in the quarter ending May 31, 2026, a decrease of -0.83%.

• Revenue: 50.65B
• Revenue Growth: +0.01%
• P/S Ratio: 0.76
• Revenue / Employee: 47.20M
• Employees: 1,073
• Market Cap: 38.33B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2026	50.65B	7.00M	0.01%
May 31, 2025	50.64B	3.75B	7.99%
May 31, 2024	46.90B	1.79B	3.98%
May 31, 2023	45.10B	1.64B	3.77%
May 31, 2022	43.46B	-5.25B	-10.78%

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 14, 2026

Data Sources Report a data error